Dr. Adam Berg, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $721.37 | 29 | 94.3% |
| Education | $43.96 | 2 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $231.28 | 9 | $0 (2024) |
| PFIZER INC. | $125.99 | 3 | $0 (2024) |
| Celgene Corporation | $69.12 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.12 | 3 | $0 (2023) |
| INTUITIVE SURGICAL, INC. | $48.29 | 1 | $0 (2024) |
| Madrigal Pharmaceuticals | $48.22 | 1 | $0 (2024) |
| Novo Nordisk Inc | $32.27 | 1 | $0 (2021) |
| IRONWOOD PHARMACEUTICALS, INC | $23.95 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $22.37 | 1 | $0 (2024) |
| Medtronic, Inc. | $21.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.36 | 12 | PFIZER INC. ($48.56) |
| 2023 | $95.92 | 6 | Celgene Corporation ($34.20) |
| 2022 | $168.16 | 5 | ABBVIE INC. ($149.75) |
| 2021 | $48.78 | 2 | Novo Nordisk Inc ($32.27) |
| 2020 | $11.69 | 1 | Janssen Pharmaceuticals, Inc ($11.69) |
| 2019 | $122.18 | 4 | PFIZER INC. ($77.43) |
| 2017 | $12.24 | 1 | Merck Sharp & Dohme Corporation ($12.24) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $48.22 | General |
| Category: LIVER DISEASE | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Immunology | ||||||
| 09/30/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/22/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: GI | ||||||
| 04/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $48.29 | General |
| Category: SURGERY | ||||||
| 04/01/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: GI | ||||||
| 01/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/12/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Neuroscience | ||||||
| 05/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2023 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $10.50 | General |
| Category: Elastography | ||||||
| 03/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Neuroscience | ||||||
| 10/11/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.41 | General |
| Category: Neuroscience | ||||||
| 10/05/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2022 | ABBVIE INC. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $110.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2021 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 07/30/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 565 | 591 | $305,230 | $66,921 |
| 2022 | 12 | 550 | 578 | $289,245 | $63,932 |
| 2021 | 13 | 578 | 604 | $299,185 | $68,075 |
| 2020 | 13 | 509 | 560 | $222,365 | $51,929 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 103 | 103 | $105,575 | $20,722 | 19.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 74 | 74 | $61,050 | $9,029 | 14.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 42 | 43 | $31,820 | $7,308 | 23.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 83 | 87 | $51,765 | $6,590 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 95 | $10,450 | $6,171 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $9,750 | $4,648 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $5,440 | $3,028 | 55.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $4,960 | $2,168 | 43.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,410 | $1,701 | 49.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 41 | $2,870 | $1,471 | 51.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,140 | $1,397 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,080 | $1,132 | 54.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,600 | $815.99 | 12.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 12 | $1,320 | $741.36 | 56.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 114 | 114 | $117,875 | $22,350 | 19.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 60 | 60 | $49,500 | $6,239 | 12.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 78 | $46,410 | $6,195 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 92 | $10,120 | $6,143 | 60.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 35 | 35 | $25,900 | $6,092 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $11,750 | $5,536 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 47 | $7,520 | $4,388 | 58.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 51 | $3,570 | $1,942 | 54.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $3,410 | $1,721 | 50.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $8,880 | $1,524 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $2,880 | $1,076 | 37.4% |
About Dr. Adam Berg, MD
Dr. Adam Berg, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629251251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Berg, MD has received a total of $765.33 in payments from pharmaceutical and medical device companies, with $306.36 received in 2024. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($721.37).
As a Medicare-enrolled provider, Berg has provided services to 2,202 Medicare beneficiaries, totaling 2,333 services with total Medicare billing of $250,856. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Syracuse, NY
- Active Since 12/05/2007
- Last Updated 02/10/2014
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629251251
Products in Payments
- RINVOQ (Biological) $162.78
- XELJANZ (Drug) $98.65
- ZEPOSIA (Drug) $69.12
- Da Vinci Surgical System (Device) $48.29
- RESMETIROM (Drug) $48.22
- SKYRIZI (Biological) $28.01
- VELSIPITY (Drug) $27.34
- LINZESS (Drug) $24.19
- Linzess (Drug) $23.95
- ENTYVIO (Biological) $22.67
- DUPIXENT (Biological) $22.37
- INTERSTIM (Device) $21.00
- TREMFYA (Drug) $19.68
- VOWST (Biological) $19.44
- OMVOH (Drug) $18.17
- Motegrity (Drug) $17.00
- ZEPATIER (Drug) $12.24
- Entyvio (Biological) $11.45
- FibroScan (Device) $10.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144